Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis
Key facts
- Who runs it
- University of Utah
- Where
- Los Angeles and Salt Lake City, United StatesSee the 2 sites
- Trial code
- Status
- Recruiting
- People taking part
- 110 people, planned
- Started
- 21 Oct 2025
- Expected to end
- 31 Mar 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Decision support tool
- Record updated
- 10 August 2026
Who can take part
- Age
- 8 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Parent-child dyads of children with neuromuscular scoliosis who speak English and Spanish
- Child is between ages 8-21 years of age and they are coming into the pediatric orthopaedic surgery clinic for consultation about potential surgery for NMS
- NMS is defined as having neurologic impairment (NI) and scoliosis using relevant ICD-9 or ICD-10 codes from Feudtner, et al. 2014 or Berry, et al. 2012. or a qualifying diagnosis per the Pediatric Spine Study Group definition of NMS
- All pediatric orthopaedic surgeons and neurosurgeons who treat neuromuscular scoliosis at our study sites will be eligible participants
Who cannot take part
- Children with the diagnosis of Becker's muscular dystrophy due to potential disease modifying therapies that may alter curve progression
- Families whose child with NMS is less than 8 years of age at time of orthopaedic consultation because surgery at a younger age usually indicates an atypical case
Where in United States
- Children's Hospital Los AngelesLos Angeles, United StatesContact: Amberly ThaiTaking people
- University of UtahSalt Lake City, United StatesContact: Angela ZhuTaking people
About the trial
What the trial wants to find out
The goal of this pilot hybrid type I efficacy/implementation trial is to assess a newly developed decision support tool patients, parents, and providers to use during surgical treatment decision making for neuromuscular scoliosis (NMS). Results from this pilot will inform the design of a future larger effectiveness trial of the decision support tool.
Read full original descriptionShow less
Participants will either receive usual care or receive the decision support tool. Researchers will assess the decision made, decision quality, individual affective, cognitive, and behavioral effects, and feasibility and acceptability of tool use. They will also collect potential barriers and facilitators to implementation and feedback about the tool and study design to maximize likelihood of successful deployment of the tool into clinical practice and inform the design of a future trial. The outcomes measures will be used to inform potential effect size estimates to inform a future trial.
The 2 groups in the trial
- Usual careNo study treatment, for comparison
Participants receive usual care
- Decision support toolTreatment being tested
Participants receive the novel decision support tool
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis - Aims 2 and 3
- Record updated
- 10 August 2026